Paul Badawi sold $277k of SGHT
President and CEO at Sight Sciences, Inc.. 37,226 shares at an average of $7.45, traded Jan 2, 2026, filed Jan 6, 2026.
Score components
- +25RoleCEO
- +14Trade size$277k at market
- 0Share of holdings soldSold 0.6% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -23.8%, 3m -53.1%, 6m -28.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-005006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | SOpen-market sale Common Stock | -25,356 | $7.43 | $188k | 5,937,146 | Jan 6, 2026 |
| Jan 6, 2026 | SOpen-market sale Common Stock | -11,870 | $7.48 | $89k | 5,925,276 | Jan 6, 2026 |
Related signals
Other insiders at Sight Sciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $71k 7,797 shares | -0% | |
| 33Weak | Sight Sciences, Inc. | Paul Badawi President and CEO | $268k 29,653 shares | -0% | |
| 27Weak | Sight Sciences, Inc. | Alison Bauerlein Chief Operating Officer | $224k 25,260 shares | -4% | |
| 25Weak | Sight Sciences, Inc. | James Rodberg Chief Financial Officer | $64k 7,208 shares | -3% | |
| 15Weak | Sight Sciences, Inc. | Brenton Taylor EVP, Operations & R&D | $26k 2,988 shares | -1% | |
| 26Weak | SGHTbuy Sight Sciences, Inc. | Staffan Encrantz director, owner | $69k 14,100 shares | +1% | |
| 8Weak | Sight Sciences, Inc. | Alison Bauerlein Chief Operating Officer | $65k 12,728 shares | -2% | |
| 17Weak | Sight Sciences, Inc. | Jeremy B. Hayden Chief Legal Officer | $49k 13,761 shares | -4% | |
| 15Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $28k 8,168 shares | -0% | |
| 30Weak | Sight Sciences, Inc. | Paul Badawi President and CEO | $108k 29,244 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.